HDL phospholipid: A natural inhibitor of Alzheimer's amyloid β-fibrillogenesis? [2]

Koudinov A.R.^{1, 2, 3, 4, 6} , Koudinova N.V.^{1, 2, 4} , Berezov T.T. ^{1, 2, 5} , Ivanov Y.D.¹

Clinical Chemistry and Laboratory Medicine

10

Английский

993-994

Опубликовано

Внешняя ссылка

37

1999

• ¹ Institute of Biomedical Chemistry, Moscow, Russian Federation
• ² Russian Academy of Medical Sciences, Moscow, Russian Federation
• ³ Natl. Mental Health Research Center, Moscow, Russian Federation
• ⁴ Weizmann Institute, Department of Neurobiology, Rehovot, Israel
• ⁵ Department of Biochemistry, Russ. People's Friendship Univ. S., Moscow, Russian Federation
• ⁶ Department of Neurobiology, Brain Research Jaglom Bldg., Weizmann Institute of Science, Rehovot 76100, Israel

amyloid beta protein; apolipoprotein; dimyristoylphosphatidylcholine; high density lipoprotein; phosphatidylcholine; phospholipid; Alzheimer disease; competitive inhibition; human; letter; priority journal; protein binding; protein cerebrospinal fluid level; protein secondary structure; proteoliposome; Raman spectrometry; solution and solubility; Alzheimer Disease; Amyloid beta-Protein; Circular Dichroism; Dimyristoylphosphatidylcholine; Humans; Lipoproteins, HDL; Neurofibrils; Protein Structure, Secondary; Spectrum Analysis, Raman

19.10.2018

19.10.2018

https://repository.rudn.ru/ru/records/article/record/526/